Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

JONATHAN C ROBERTS

Allopathic & Osteopathic Physicians Pediatrics

NPI
1871757070
CMS profile
1014764
Location
PEORIA, IL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2023 · Entire year

$111,532.85

68 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

Other CMS categories — not shown on this page

Research Payments

CMS also publishes Research Payments as a separate dataset. This site does not currently mirror it, and no research figure is shown on this page. This provider appears in that dataset.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

These records are published by CMS and can be viewed on this provider’s official CMS record. View this provider on CMS Open Payments ↗

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2023 · entire year · sorted by reported total

By paying entity

PY2023 · entire year · sorted by reported total

Paying entityAmountRecords
GENZYME CORPORATION $39,280.38 23
Takeda Pharmaceuticals U.S.A., Inc. $32,399.90 26
Novo Nordisk Inc $20,424.27 9
PFIZER INC. $6,250.00 2
Octapharma USA, Inc. $5,231.64 3
Genentech, Inc. $4,782.66 3
SANOFI-AVENTIS U.S. LLC $3,164.00 2

Payment records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2023 · Physicians and non-physician practitioners · CMS publication 2026-06-30

68 matching records · $111,532.85 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 68 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–50 of 68.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
GENZYME CORPORATION $2,211.0012/10/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261061215155 CMS
Takeda Pharmaceuticals U.S.A., Inc. $66.0312/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261055568307 CMS
Novo Nordisk Inc $6.8012/06/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261003161767 CMS
Novo Nordisk Inc $113.8512/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261003161775 CMS
Novo Nordisk Inc $199.1212/06/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261003161783 CMS
Novo Nordisk Inc $6,918.7512/06/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261003161805 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,310.0011/23/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261055568301 CMS
SANOFI-AVENTIS U.S. LLC $2,531.0011/18/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261050249455 CMS
SANOFI-AVENTIS U.S. LLC $633.0011/18/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261050249459 CMS
Octapharma USA, Inc. $2,500.0011/10/2023 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/20261042734071 CMS
Octapharma USA, Inc. $731.6411/10/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261042734073 CMS
GENZYME CORPORATION $5,436.0010/24/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261050249427 CMS
GENZYME CORPORATION $108.6410/24/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261050249431 CMS
GENZYME CORPORATION $22.9710/24/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261050249467 CMS
GENZYME CORPORATION $292.7910/24/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261050249471 CMS
GENZYME CORPORATION $3.8010/24/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261050249475 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,407.5010/13/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261055568295 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,006.2509/28/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261055568291 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,006.2509/14/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261055568285 CMS
Novo Nordisk Inc $1,012.0008/14/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261002370781 CMS
Takeda Pharmaceuticals U.S.A., Inc. $401.2508/04/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261055568279 CMS
Takeda Pharmaceuticals U.S.A., Inc. $3.4807/31/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261055568267 CMS
Takeda Pharmaceuticals U.S.A., Inc. $7,000.0007/31/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261055568273 CMS
Novo Nordisk Inc $6,098.7506/27/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261002370805 CMS
GENZYME CORPORATION $2,114.0006/08/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261050249383 CMS
Novo Nordisk Inc $2,700.0006/03/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261002370793 CMS
GENZYME CORPORATION $2,114.0005/31/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261050249359 CMS
GENZYME CORPORATION $2,114.0005/10/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261050249351 CMS
GENZYME CORPORATION $2,114.0004/27/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261050249333 CMS
Novo Nordisk Inc $2,700.0004/21/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261003161799 CMS
GENZYME CORPORATION $28.3004/12/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261050249309 CMS
GENZYME CORPORATION $6,342.0004/12/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261050249313 CMS
GENZYME CORPORATION $335.8004/12/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261050249317 CMS
GENZYME CORPORATION $98.0804/12/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261050249321 CMS
GENZYME CORPORATION $571.5304/12/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261050249325 CMS
GENZYME CORPORATION $18.4704/12/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261050249329 CMS
Novo Nordisk Inc $675.0004/12/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261003161791 CMS
GENZYME CORPORATION $5,691.0004/07/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261050249345 CMS
Takeda Pharmaceuticals U.S.A., Inc. $1,500.0004/07/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261055568261 CMS
GENZYME CORPORATION $2,114.0003/23/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261050249297 CMS
GENZYME CORPORATION $604.0003/22/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261050249447 CMS
Takeda Pharmaceuticals U.S.A., Inc. $1,750.0003/22/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261055568255 CMS
Takeda Pharmaceuticals U.S.A., Inc. $1,750.0003/16/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261055568209 CMS
Takeda Pharmaceuticals U.S.A., Inc. $9,630.0003/16/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261055568215 CMS
Takeda Pharmaceuticals U.S.A., Inc. $6.9603/16/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261055568220 CMS
Takeda Pharmaceuticals U.S.A., Inc. $78.2603/16/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261055568225 CMS
Takeda Pharmaceuticals U.S.A., Inc. $17.1303/16/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261055568231 CMS
Takeda Pharmaceuticals U.S.A., Inc. $153.2903/16/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261055568237 CMS
Takeda Pharmaceuticals U.S.A., Inc. $64.8003/16/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261055568243 CMS
Takeda Pharmaceuticals U.S.A., Inc. $16.3603/16/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261055568249 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $55,888.82 84
PY2020 $55,110.83 35
PY2021 $41,557.22 38
PY2022 $109,737.46 78
PY2023 $111,532.85 68
PY2024 $106,541.95 64
PY2025 $107,287.27 43

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Cite this record.

Plain
JONATHAN C ROBERTS, NPI 1871757070. IndustryPayments, data edition 2026-07-26T04:22:22Z. https://industrypayments.org/provider/npi-1871757070.
APA 7
IndustryPayments. (2026). JONATHAN C ROBERTS, NPI 1871757070 (Data edition 2026-07-26T04:22:22Z) [Data set]. https://industrypayments.org/provider/npi-1871757070
Bluebook
JONATHAN C ROBERTS, NPI 1871757070, IndustryPayments (data edition 2026-07-26T04:22:22Z), https://industrypayments.org/provider/npi-1871757070.

Source: Centers for Medicare & Medicaid Services, Open Payments.